Press Releases

Date	Title	PDF Version
Jul 06, 2006	Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Jun 16, 2006	Alexion Announces the EXPLORE Clinical Diagnostic Study for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jun 12, 2006	Alexion Pharmaceuticals Reports Positive Interim Safety and Efficacy Results for Soliris(TM) (eculizumab) From the Open-Label Phase III SHEPHERD Safety Trial in Paroxysmal Nocturnal Hemoglobinuria Patients
Jun 06, 2006	ALEXION Announces Pre-Clinical Results with Novel Anti-Cancer Antibody; Treatment Against New Potential Cancer Target Found to Stop Leukemia Tumor Growth
May 13, 2006	ALEXION Pharmaceuticals™ Antibody Therapy Shown Effective in Model for Severe Allergic Asthma
Apr 27, 2006	ALEXION Pharmaceuticals Reports First Quarter 2006 Results
Apr 25, 2006	Alexion To Present At Investor Conferences
Apr 13, 2006	Alexion Pharmaceuticals Invites You to Participate in its First Quarter Results Conference Call and Web Cast
Feb 27, 2006	ALEXION To Present At Cowen & Co. 26th Annual Health Care Conference
Feb 21, 2006	ALEXION To Present At The Citigroup 2006 Healthcare Conference

Search